2016 | A melanin-bleaching methodology for molecular and histopathological analysis of formalin-fixed paraffin-embedded | LABORATORY INVESTIGATION |
2014 | A Phase 2 Trial of Radiation Therapy With Concurrent Paclitaxel Chemotherapy After Surgery in Patients With High-Risk Endometrial Cancer: A Korean Gynecologic Oncologic Group Study | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2016 | Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer
| ONCOTARGET |
2010 | Accuracy of preoperative tests in clinical stage I endometrial cancer: the importance of lymphadenectomy | ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA |
2019 | ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer
| CANCERS |
2017 | API5 induces cisplatin resistance through FGFR signaling in human cancer cells
| EXPERIMENTAL AND MOLECULAR MEDICINE |
2014 | Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer.
| BMC CANCER |
2023 | Ascitic autotaxin as a potential prognostic, diagnostic, and therapeutic target for epithelial ovarian cancer
| BRITISH JOURNAL OF CANCER |
2015 | Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array
| DIAGNOSTIC PATHOLOGY |
2014 | ATP-Based Chemotherapy Response Assay in Primary or Recurrent Ovarian and Peritoneal Cancer
| YONSEI MEDICAL JOURNAL |
2010 | Autoantibodies against stress-induced phosphoprotein-1 as a novel biomarker candidate for ovarian cancer | GENES CHROMOSOMES & CANCER |
2017 | Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical Cancer | ANTICANCER RESEARCH |
2020 | CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer | GYNECOLOGIC ONCOLOGY |
2016 | Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer
| YONSEI MEDICAL JOURNAL |
2015 | Clinical significance of OCT4 and SOX2 protein expression in cervical cancer
| BMC CANCER |
2008 | Clinical significance of osteopontin expression in cervical cancer | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2013 | Clinical significance of serum anti-human papillomavirus 16 and 18 antibodies in cervical neoplasia | OBSTETRICS AND GYNECOLOGY |
2021 | Clinical Significance of Tumor Infiltrating Lymphocytes in Association with Hormone Receptor Expression Patterns in Epithelial Ovarian Cancer
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2019 | Combined treatment with modulated electro-hyperthermia and an autophagy inhibitor effectively inhibit ovarian and cervical cancer growth | INTERNATIONAL JOURNAL OF HYPERTHERMIA |
2024 | Comparison of Adverse Events Between PARP Inhibitors in Patients with Epithelial Ovarian Cancer: A Nationwide Propensity Score Matched Cohort Study | TARGETED ONCOLOGY |
2018 | Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models
| CANCER RESEARCH AND TREATMENT |
2021 | CRY1 Regulates Chemoresistance in Association With NANOG by Inhibiting Apoptosis via STAT3 Pathway in Patients With Cervical Cancer
| CANCER GENOMICS & PROTEOMICS |
2009 | Diagnostic and prognostic impact of osteopontin expression in endometrial cancer | CANCER INVESTIGATION |
2018 | DNA mismatch repair protein immunohistochemistry and MLH1 promotor methylation testing for practical molecular classification and the prediction of prognosis in endometrial cancer
| CANCERS |
2013 | Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancer | BIOMARKERS |
2010 | ER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139 | INTERNATIONAL JOURNAL OF ONCOLOGY |
2018 | Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression
| PLOS ONE |
2014 | Expression of Stress-Induced Phosphoprotein1 (STIP1) is Associated with Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer | GENES CHROMOSOMES & CANCER |
2019 | Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancer | INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY |
2008 | Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line. | MOLECULAR AND CELLULAR BIOCHEMISTRY |
2017 | HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells | CANCER RESEARCH |
2023 | High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer
| ONCOLOGY REPORTS |
2022 | HIGH EXPRESSION OF PHOSPHODIESTERASE 1 (PDE1A) PROMOTES POOR PROGNOSIS AND ASSOCIATED WITH PLATINUM BASED CHEMOTHERAPY RESISTANCE IN EPITHELIAL OVARIAN CANCER | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | HIGH EXPRESSION OF TRAFFICKING PROTEIN TRANSMEMBRANE P24 TRAFFICKING PROTEIN9 PROMOTES POOR PROGNOSIS OF EPITHELIAL OVARIAN CANCER | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | HIGH EXPRESSION OF VACUOLAR-ATPASE SUBUNIT ATP6V1B1 PROMOTES POOR PROGNOSIS AND TUMORIGENIC CHARACTERISTICS IN EPITHELIAL OVARIAN CANCER | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | High FKBPL expression contributes to cell proliferation by regulating the cell cycle and affects prognosis in ovarian cancer patients | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2023 | High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2018 | Histomorphological and Molecular Assessments of the Fixation Times Comparing Formalin and Ethanol-Based Fixatives. | JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY |
2020 | HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors
| NATURE COMMUNICATIONS |
2012 | Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study | EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY |
2022 | Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models
| CANCERS |
2021 | LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells
| AUTOPHAGY |
2009 | Lipocalin2 as a diagnostic and prognostic biomarker for epithelial ovarian cancer
| Thesis |
2009 | Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer
| JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY |
2013 | Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer | HUMAN PATHOLOGY |
2019 | Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor Prognosis in Patients With Epithelial Ovarian Cancer | Cancer genomics & Proteomics |
2016 | Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology
| MEDICINE |
2021 | MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors
| PLOS PATHOGENS |
2014 | MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer.
| BMC CANCER |
2018 | Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance
| JOURNAL OF CLINICAL INVESTIGATION |
2021 | Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial
| EXPERIMENTAL AND THERAPEUTIC MEDICINE |
2009 | Molecular characterization of a new ovarian cancer cell line, YDOV-151, established from mucinous cystadenocarcinoma.
| TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE |
2009 | Multiplication of neutrophil and monocyte counts (MNM) as an easily obtainable tumour marker for cervical cancer. | BIOMARKERS IN MEDICINE |
2022 | NANOG confers resistance to complement-dependent cytotoxicity in immune-edited tumor cells through up-regulating CD59
| SCIENTIFIC REPORTS |
2022 | NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells
| JOURNAL OF CELLULAR AND MOLECULAR MEDICINE |
2012 | Nanog signaling in cancer promotes stem-like phenotype and immune evasion
| JOURNAL OF CLINICAL INVESTIGATION |
2023 | Nectin-4 as a Predictive Marker for Poor Prognosis of Endometrial Cancer with Mismatch Repair Impairment
| CANCERS |
2008 | Neutrophil-to-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosis | FERTILITY AND STERILITY |
2018 | Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF | CELL DEATH AND DIFFERENTIATION |
2016 | Over-expression of BMI1 is associated with favorable prognosis in cervical cancer
| INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY |